Pain Relief
NDC Package 70355-001-10
Package Information
Pain Relief is a medication used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever. Marketed by Zhejiang Dongyang Yinda Biology Co., Ltd, this product is identified by NDC 70355-001 and is authorized under FDA application part348.
Identification & Billing
- RxCUI: 1599164 - lidocaine 4 % / menthol 5 % / methyl salicylate 4 % Medicated Patch
- RxCUI: 1599164 - lidocaine 0.04 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.04 MG/MG Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70355 - Zhejiang Dongyang Yinda Biology Co., Ltd
- 70355-001 - Pain Relief
- 70355-001-10 - 15 POUCH in 1 BOX / 5 PATCH in 1 POUCH / .408 g in 1 PATCH
- 70355-001 - Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70355-001). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70355-001-10 identifies a specific commercial package of 15 pouch in 1 box / 5 patch in 1 pouch / .408 g in 1 patch of Pain Relief, labeled by Zhejiang Dongyang Yinda Biology Co., Ltd. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Zhejiang Dongyang Yinda Biology Co., Ltd on December 30, 2015. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
This drug is used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever.
How is this Zhejiang Dongyang Yinda Biology Co., Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70355000110. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
